2019 Venture-Backed Portfolio Company of the YearPresented at the IVCA Annual Awards Dinner presented by Kirkland & Ellis LLP on December 9, 2019
Venture Capital Awardee is LivongoLead investor: 7wire Ventures Livongo, a leading Applied Health Signals company, was founded in 2013 and received $8 million in 1st round venture funding. Subsequent rounds between 2014 & 2018 resulted in total VC funding of $237 million. In July of 2019, Livongo had an initial public offering which raised $355 million at $28 per share, which made the company one of the best performing digital health IPOs in history. Today, Livongo has over 770 clients incusing 4 of the 7 largest health insurers, two of the nation’s largest pharmacy benefit managers, and more then 20 percent of the Fortune 500.
Livongo offers a whole person platform that empowers people with chronic conditions to live better and healthier lives, beginning with diabetes and now including hypertension, weight management, diabetes prevention, and behavioral health. Livongo pioneered the category of Applied Health Signals to offer Members clinically-based insights that make it easier to stay healthy. Livongo’s team of data scientists aggregate and interpret substantial amounts of health data and information to create actionable, personalized and timely health signals delivered to Livongo Members exactly when they need them. The Livongo approach delivers better clinical and financial outcomes while creating a different and better experience for people with chronic conditions.
Begun in 2010, the Portfolio Company of the Year Award recognizes a venture capital-backed and a private equity-backed company based on the following criteria:
2018: Aptinyx (Venture-backed)
2011: Accretive Health (Venture-backed)
2010: Initiate Systems, Inc. (Venture-backed)
|